Sales to outside customers increased significantly to 16,655 million yen
(up 65.9% year-on-year).
Hydrox Laboratories, which became a subsidiary in October 2021 that manufactures
and sells medical disinfectants and other products, made a significant
contribution to the increase in sales.
Segment profit (operating profit basis) increased significantly to 724
million yen (up 234.6% year-on-year) due to efficient use of selling, general
and administrative expenses, despite deterioration of the cost of sales
ratio due to higher raw material procurement costs and higher labor costs
caused by labor shortages.